You have no items in your shopping cart.
Search results for: 'HEK293'
RecombinantIL-6,Rat(HEK293-expressed) [orb1494636]> 95% as analyzed by SDS-PAGE.
21~26 kDa , observed by reducing SDS-PAGE.
HEK 293
1 mg, 25 μg, 5 μg- RecombinantIL-22,Human(HEK293-expressed) [orb1494638]
> 95% as analyzed by SDS-PAGE.
16~28 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantIL-1β,Rat(HEK293-expressed) [orb1494640]
> 95% as analyzed by SDS-PAGE.
17~22 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg - RecombinantIL-12,Human(HEK293-expressed) [orb1494641]
> 95% as analyzed by SDS-PAGE and HPLC.
Approximately 75 kDa, consisting of a 306 amino acid residue p40 subunit and a 197 amino acid residue p35 subunit.
HEK 293
25 μg, 5 μg, 1 mg - RecombinantIL-1RA,Human(HEK293-expressed) [orb1494643]
> 95% as analyzed by SDS-PAGE and HPLC.
18-23 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantG-CSF,Rat(HEK293-expressed) [orb1494648]
> 95% as analyzed by SDS-PAGE and HPLC.
25~28 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantFractalkine/CX3CL1,Rat [orb1494649]
> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantENA-78/CXCL5,Human(HEK293-expressed) [orb1494651]
> 98% as analyzed by SDS-PAGE.
8.5 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg - RecombinantCT‑1,Mouse [orb1494652]
> 95% as analyzed by SDS-PAGE.
22~27 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantCNTF,Human(HEK293-expressed) [orb1494653]
> 95% as analyzed by SDS-PAGE.
22~28 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg